PolyNovo
Australia - Port MelbourneBiotechnology
Focus: PolyNovo is an Australian biotechnology company specializing in biodegradable materials for dermatological applications, operating as a public company with a focused portfolio in wound care and tissue regeneration.
Profile data last refreshed 11h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Total Funding
$25M
Open Jobs
0
About PolyNovo
AI assessmentNot HiringNo open roles listed right now. Follow PolyNovo to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
SynPath Acellular Dermal Matrix plus Off-loading Device
Diabetic FootClinical Trials (1)
NCT05506215Randomized Clinical Study Comparing SynPath to Standard of Care in Treatment of Chronic Diabetic Foot Ulcers
N/AHelp build intelligence for PolyNovo
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.